Ding, Hongying
Xu, Yue
Cheng, Yinhong
Zhou, Haoliang
Dong, Shiye
Wu, Jian
Lv, Jin
Hu, Xiaosheng
Tang, Oushan
Article History
Received: 3 September 2022
Accepted: 2 August 2023
First Online: 9 September 2023
Declarations
:
: This research has been performed in accordance with the Declaration of Helsinki and were approved by the Ethics Committee of Shaoxing Second hospital. Written informed consent was obtained from all participants included in the study.
: Not applicable.
: Y. Xu. and S.Dong are employers of the company Shanghai Biotecan Pharmaceuticals Co., Ltd. The remaining authors declare no conflict of interest.